The perspectives of pharmacological correction of depressive disorders and cognitive deficit as post-traumatic epilepsy leading syndromes
DOI:
https://doi.org/10.12775/JEHS.2022.12.02.037Keywords
depressive disorders, cognitive deficit, brain injury, vortioxetine, pathogenetic mechanisms, treatmentAbstract
Traumatic brain injury is the leading cause of symptomatic epilepsy at a young age. Post-traumatic epilepsy (PTE) is the main factor in disabling patients of working age and impairs the quality of life. Comorbid pathology in the form of psychoemotional and cognitive disorders essentially has a single pathogenetic mechanism on the part of traumatic brain disease. There are problems with differential diagnosis between comorbid and direct manifestations of PTE. The above dictates the need to develop modern complex approaches to the treatment of PTE and correction of accompanying and comorbid pathological conditions. Author tries to develop new pathogenetically adequate approaches to the treatment of PTE with correction of the psycho-emotional sphere and cognitive deficit. 44 patients with PTE were examined. The average period of its formation reached 10.3±4.2 years, and the frequency of attacks – 2.4±0.9 per month. Focal attacks prevailed (61.4%). In addition to standard long-term anticonvulsant monotherapy, the main group (32 patients) was prescribed ethylmethylhydroxyperidine succinate and vortioxetine. The control group (12 patients) received only anticonvulsant therapy.
When using the proposed complex treatment, the number of people with depression decreased from 25 (56.8%) to 10 (22.7%) cases, that is, by 2.5 times (P <0.05). In the main group, from 59.4% to 21.9%, i.e. 2.7 times (Р<0.05). In the control – from 50.0% to 41.7% (Р>0.05). 37.5% registered positive dynamics in relation to pathological activity on the electroencephalogram. According to the Luria A. R. test, the average values of the obtained data at all stages of word presentation were probably higher than at the beginning of the study. Indicators of long-term memory changed similarly.
Thus, the proposed treatment approach has a beneficial effect on the main pathogenetic links of the development of PTE, its course and corrects cognitive deficits, psychoemotional layers, which are comorbid conditions.
References
Antsyborov VA, Dubatova IV. Depressive spectrum disorders in neurological practice: is there a place under the sun, or who should treat patients? Interactive science. 2021; 3(58): 9-30 [In Russian].
Borysenko OA. Clinical-pathogenetic features of autonomic disorders and their correction in ATO participants in the remote period of craniocerebral trauma. Abstr. PhD Thesis, Uzhhorod; 2021: 21 [In Ukrainian].
Borisenko OA, Zaitseva TA, Stoyanov AN, Kolesnik EA. Paroxysmal conditions in diseases of the internal organs. Jornal of Education, Нelth and Sport. 2017; 7(1): 437-448 [In Russian].
Burd SG, Rider FK, Badalyan OL, Avakyan GG, Chukanova AS. Depression and epilepsy: two sides of the same coin. International Journal of Neurology. 2011; 8(46): http://www.mif-ua.com/archive/article/25697 [In Russian].
Burchinsky SG. Choice of anticonvulsant in epilepsy monotherapy strategy. International Journal of Neurology. 2011; 2: 78-82 [In Russian].
Voronina TA, Ivanova EA. The use of the drug Mexidol in the complex treatment of patients with pharmacoresistant partial epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2019; 119(4): 115-124 [In Russian].
Gromova OA, Torshin IYu, Stakhovskaya LV, Pepelyaev EG, Semenov VA, Nazarenko AG. Experience in the use of mexidol in neurological practice. Journal of Neurology and Psychiatry. 2018; 10: 45-48 [In Russian].
Dubenko AE. Epilepsy in the elderly, features of the clinic, diagnosis and treatment. Neuro NEWS. 2010; 2(1): 5-15 [In Russian].
Zhilyaev SO, Shtrigol SYu. Comparative analysis of the influence of corvitin and lipoflavone on indicators of energy metabolism in the brain of rats based on the model of severe craniocerebral injury. Zaporozhye Medical Journal. 2013; 2(77): 21–24 [In Ukrainian].
Zenkov LR, Ronkin MA. Functional diagnosis of nervous diseases. – A Guide for Physicians. Moscow: “MEDpress-inform; 2013: 488 [In Russian].
Ioshina NN, Korsunskaya .L. Epidemiological characteristics of symptomatic epilepsy in patients with post-traumatic cystic formations of the brain. International Journal of Neurology. 2014; 5(67): 34-36 [In Russian].
Kadzhaya NV, Dyadechko AA, Beloshitsky VV, Bondar TS, Bolyukh AS, Kuzmenko DA. Improving the quality of life of patients with post-traumatic epilepsy. Ukrainian neurosurgical journal. 2007; 3: 9-11 [In Ukrainian].
Kaptalan AO, Stoyanov OM, Ostapenko IO, Kirchev VV. The effect of the combined use of Mexiprim and Semax on the behavioral correlates of post-traumatic epilepsy in rats. Actual problems of transport medicine. 2021; 1(63): 76-84 [In Ukrainian].
Korshniak VO, Stoyanov OM, Vastyanov RS, Beseda AYa, Andreyeva TO, Beseda YaV, Stoyanov AO. Vegetative dysfunctions due to neurotrauma and modern possibilities of their correction. Herald of maritime medicine. 2022; 2(95): 91-98 [In Ukrainian].
Levada O. New goals and means of treating depression in the 21st century: from a neurobiological model to the first clinical results. Health of Ukraine. 2015; 6(3) : 15-16 [In Ukrainian].
Litovchenko TA, Mikhailov BV. Depression and epilepsy. NeuroNews. 2008; 3(1): 7-12 [In Russian].
Mar'enko LB. Therapeutic pathomorphosis of epilepsy in the light of the results of treatment with drugs of different generations. S.S. Korsakov Journal of Neurology and Psychiatry. 2014; 114(4): 18-22 [In Russian].
Matyash MM, Marchenko OM. Modern approaches to the treatment of traumatic brain disease (traumatic encephalopathy). International Neurological Journal. 2015; 6: 137-143 [In Ukrainian].
Workshop on general psychology. Ed. by T.I. Pashukova. K: T-vo “Znannia”; 2000: 204 [In Ukrainian].
Stoyanov OM, Muratova TM, Kolesnyk OO, Oliynyk SM. Neurovegetative disorders in the post-traumatic epilepsy clinic. Ukrainian Journal of Psychoneurology. 2017; 25(1): 108 [In Ukrainian].
Chernenko II, Chukhno IA. Epidemiological and clinical aspects of the consequences of brain injury. Bulletin of social hygiene and health care organization of Ukraine. 2017; 4(74): 5-11 [In Ukrainian].
Barco AM, Martinez MR, Restrepo D. Depression in people with epilepsy. What is the connection. Rev Colomb Psiquiatr (Engl Ed). 2020;49(1):53-61.
Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012; 78(20: 1548-1554.
Gupta PK, Sayed N, Ding K, Agostini MA, Van Ness PC, Yablon S, Madden C et al. Subtypes of post-traumatic epilepsy: Clinical, electrophysiologic, and imaging features. J Neurotrauma. 2014;31(16):1439-1443.
Hua LH, Hersh CM, Tian F, Mowry EM, Fitzgerald KC. Clinical characteristics of a large multi-center cohort of people with multiple sclerosis over age 60. Mult Scler Relat Disord. 2021;47:102637. doi: 10.1016/j.msard.2020.102637
Klineova S, Brandstadter R, Fabian MT, Sand IK, Krieger S, Leavitt VM, Lewis C et al. Psychological resilience is linked to motor strength and gait endurance in early multiple sclerosis. Mult Scler. 2020;26(9):1111-1120.
Lebrun C, Gély-Nargeot M-C, Rossignol A, Geny C, Bayard S. Efficacy of cognitive behavioral therapy for insomnia comorbid to Parkinson's disease: A focus on psychological and daytime functioning with a single-case design with multiple baselines. J Clin Psychol. 2020 Mar;76(3):356-376.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Bonaguro EF, Vellante F, Fornaro M et al. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant Vortioxetine. Expert Rev Neurother. 2016; 16(5): 483-495.
Stoyanov OM, Vastyanov RS, Myronov OO, Kalashnikov VI, Babienko VV, Hruzevskiy OA, Turchin MI. Vegetative system pathogenetic role in chronic brain ischemia, cerebral hemodynamics disorders and autonomous dysregulation. World of Medicine and Biology. 2022; 2(80): 162-168.
Teymoori A, Gorbunova A, Haghish FE, Real R, Zeldovich M, Wu Yi-J, Polinder S et al. Factorial structure and validity of Depression (PHQ-9) and Anxiety (GAD-7) scales after traumatic brain injury. J Clin Med. 2020;9(3):873. doi: 10.3390/jcm9030873
Vastyanov RS, Stoyanov OM, Platonova OM, Yermuraki PP, Ostapenko IO, Tatarko SV, Bibikova VM. Pathogenetic mechanisms of convulsive depressive syndrome in conditions of kindling model of epileptogenesis. World of Medicine and Biology. 2021; 1(75): 181-186.
Vastyanov RS, Kirchev VV, Muratova TM, Kashchenko OA, Vastyanova OV, Tatarko SV, Zayats LM. Comparative analysis of motor and emotional behavioral disorders in conditions of experimental chronic ischemic and chronic convulsive syndromes. World of Medicine and Biology. 2021; 2(76): 183-188.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983; 67(6): 361-370
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 I. Ostapenko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 275
Number of citations: 0
